|
|
Volumn 13, Issue 1, 2012, Pages 19-20
|
|
Conference scene: UK pharmacogenetics and stratified medicine network
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
BIOLOGICAL MARKER;
BISPHOSPHONIC ACID DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HLA DQA1 ANTIGEN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INTERLEUKIN 8;
LAPATINIB;
NEUROLEPTIC AGENT;
PAZOPANIB;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANGIONEUROTIC EDEMA;
ARMS2 GENE;
BONE NECROSIS;
BREAST CANCER;
CFH GENE;
CLINICAL TRIAL (TOPIC);
COLORECTAL CANCER;
CONFERENCE PAPER;
COUGHING;
DRUG INDUSTRY;
DRUG RESEARCH;
GENE;
GENETIC RISK;
GENETIC VARIABILITY;
GENOTYPE;
HAPLOTYPE;
HEALTH CARE FACILITY;
HEALTH CARE ORGANIZATION;
HUMAN;
HYPONATREMIA;
LIVER INJURY;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
METHODOLOGY;
MYOPATHY;
PATIENT CARE;
PATIENT SAFETY;
PHARMACOGENETICS;
PHENOTYPE;
PRESCRIPTION;
RETINA MACULA AGE RELATED DEGENERATION;
SCORING SYSTEM;
SEQUENCE ANALYSIS;
SIDE EFFECT;
SINGLE NUCLEOTIDE POLYMORPHISM;
TENDON RUPTURE;
UNITED KINGDOM;
VEGF GENE;
WEIGHT GAIN;
CLINICAL TRIALS AS TOPIC;
COMPUTATIONAL BIOLOGY;
GREAT BRITAIN;
HUMANS;
INDIVIDUALIZED MEDICINE;
PHARMACOGENETICS;
PROTEOMICS;
|
|
EID: 83755207549
PISSN: 14622416
EISSN: 17448042
Source Type: Journal
DOI: 10.2217/pgs.11.162 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
